In an article published on Friday, The Daily Caller reported about NLPC’s shareholder proposal that will be up for a vote at the Disney annual meeting on April 3. From the story:
In Disney’s 2024 “Notice of Annual Meeting of Shareholders and Proxy Statement,” Disney details how the NLPC and [National Center for Public Policy Research] notified the company that they intend to present proposals focused on [gender] issues. Within the same document, Disney “affirms” that people who suffer from gender dysphoria can “transition to a different sex.” However, “an increasing body of scientific evidence shows no benefits result from such medical treatments,” the NLPC argues. They go on to cite the European and American medical community’s “increasing” caution about gender-transition “therapies.”
“Victims report transition treatments and surgeries are harmful. Examples include long-lasting or permanent outcomes like chronic pain, sexual dysfunction, unwanted hair loss or hair gain, menstrual irregularities, urinary problems, and other complications,” the statement continues. “Rather than resolve health problems ‘gender affirming’ therapies instead often exacerbate them. In such instances, those who desire to ‘detransition’ cannot find medical care or insurance coverage, and are permanently mutilated. Many of these sufferers litigate against those who misled or harmed them.”
But as de-transitioners are protected under “gender identity” and “sexual orientation” aspects of the Equal Employment Opportunity Commission (EEOC), they cannot be discriminated against in any way, resulting in Disney covering transition procedures.
Shareholders have asked the board to issue a report on Disney’s funding of gender care and related activities by Dec. 31, 2024, and whether there are any “benefit gaps” related to gender dysphoria, as well as “associated reputational, competitive, operational and litigative risks.”
Read the full article at The Daily Caller.
